Controversy and Consensus on the Management of Patients With Pseudomyxoma PeritoneiSpringer Science and Business Media LLC - Tập 14 - Trang 365-373 - 2013
Jason E. Faris, David P. Ryan
Pseudomyxoma peritonei and peritoneal carcinomatosis derived from appendiceal epithelial tumors are controversial entities from classification to treatment. For the former entity, multiple classification systems have been attempted to distinguish indolent from more aggressive subtypes. The treatment of the low grade variants is managed with serial cytoreduction surgery, with data indicating possib...... hiện toàn bộ
Central Nervous System Prophylaxis and Treatment in Acute LeukemiasSpringer Science and Business Media LLC - Tập 23 - Trang 1829-1844 - 2022
Susan Y. Wu, Nicholas J. Short, Lewis Nasr, Bouthaina S. Dabaja, Penny Q. Fang
Improvements in systemic therapy in the treatment of acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML) have improved patient outcomes and reduced the incidence of CNS relapse. However, management of patients with CNS disease remains challenging, and relapses in the CNS can be difficult to salvage. In addition to treatment with CNS-penetrant systemic therapy (high-dose methotrexat...... hiện toàn bộ
Therapeutic Advances in the Management of Patients with Advanced RET Fusion-Positive Non-Small Cell Lung CancerSpringer Science and Business Media LLC - Tập 22 - Trang 1-20 - 2021
Fangdi Sun, Caroline E. McCoach
Screening for activating driver gene alterations at the time of diagnosis is the standard of care for advanced non-small cell lung cancer (NSCLC). Activating RET fusions are identified in approximately 1–2% of NSCLCs and have emerged as a targetable driver alteration. Selpercatinib and pralsetinib are RET-selective tyrosine kinase inhibitors (TKIs) with encouraging efficacy, intracranial activity,...... hiện toàn bộ
BEYOND KRAS: Other Markers and Potential Treatment Strategies for KRAS Mutant and Wild-type PatientsSpringer Science and Business Media LLC - Tập 12 - Trang 126-135 - 2011
Andrea Cercek, Leonard Saltz
Despite the advances and new drug discoveries, the best drug in metastatic colorectal cancer (mcrc) is 5-fluorouracil. This drug is the backbone of FOLFOX and FOLFIRI which are the standard first line cytotoxic regimens in the metastatic setting. The efficacies of these two regimens are equivalent, and the selection of one over the other is largely based on the side effect profile. Bevacizumab is ...... hiện toàn bộ
Update on the Treatment of Early-Stage Triple-Negative Breast CancerSpringer Science and Business Media LLC - Tập 19 - Trang 1-19 - 2018
Priyanka Sharma
Triple-negative breast cancer (TNBC) accounts for 15% of all breast cancers and is associated with poor long-term outcomes compared to other breast cancer subtypes. Currently, chemotherapy remains the main modality of treatment for early-stage TNBC, as there is no approved targeted therapy for this subtype. The biologic heterogeneity of TNBC has hindered the development and evaluation of novel age...... hiện toàn bộ
Tailoring Treatment for Patients with Inflammatory Breast CancerSpringer Science and Business Media LLC - Tập 24 - Trang 580-593 - 2023
Alexandra B. Newman, Filipa Lynce
Inflammatory breast cancer (IBC) is a rare but aggressive subtype of breast cancer that has a propensity for locoregional recurrence and distant metastasis and is associated with a disproportionately high percentage of breast cancer deaths. IBC is not resectable at initial diagnosis and trimodality therapy is considered the standard treatment for IBC. This includes systemic therapy upfront, follow...... hiện toàn bộ
Novel Surgical Strategies in the Treatment of Gynecological MalignanciesSpringer Science and Business Media LLC - Tập 19 - Trang 1-16 - 2018
Martina Aida Angeles, Carlos Martínez-Gómez, Federico Migliorelli, Marie Voglimacci, Justine Figurelli, Stephanie Motton, Yann Tanguy Le Gac, Gwénaël Ferron, Alejandra Martinez
The main advancement in the surgical treatment of early cervical cancer has been a de-escalation in the radical surgical approach of early stage disease. Similarly, sentinel lymph node detection with cervical tracer injection can be performed alone in microscopic tumors (stage IA) while additional lymphadenectomy is still performed in macroscopic tumors (IB1 and IIA). Parametrial resection has bee...... hiện toàn bộ
Fertility Sparing Strategies in Patients Affected by Placental Site Trophoblastic TumorSpringer Science and Business Media LLC - Tập 18 - Trang 1-9 - 2017
Benito Chiofalo, Vittorio Palmara, Antonio Simone Laganà, Onofrio Triolo, Salvatore Giovanni Vitale, Francesca Conway, Giuseppe Santoro
Placental site trophoblastic tumor (PSTT) is the least common and the most ambiguous gestational trophoblastic tumor. Presentation of PSTT may occur in the course of gestation or from 1 week to 14 years after a normal or an abnormal pregnancy (mole, ectopic pregnancy, abortion). The indicators of aggressive behavior for this tumor are not well established. Due to the rarity of this disease that us...... hiện toàn bộ
Endometrial carcinomaSpringer Science and Business Media LLC - Tập 2 - Trang 129-135 - 2001
Warner K. Huh, J. Michael Straughn, F. Joseph Kelly, Larry C. Kilgore
Endometrial cancer is a common tumor of the female genital tract. The majority of women diagnosed with endometrial cancer present with early-stage disease. Although the optimal treatment for these patients requires hysterectomy, the use of lymphadenectomy is controversial. Growing scientific data support the use of lymphadenectomy in all patients diagnosed with endometrial cancer. When performed b...... hiện toàn bộ
Diagnosis and management of ductal carcinoma in situSpringer Science and Business Media LLC - Tập 5 - Trang 131-144 - 2004
Amina Khan, Lisa A. Newman
Ductal carcinoma in situ (DCIS) is a preinvasive form of breast cancer that has increased in incidence over the past 25 years, primarily as a result of mammographically detected microcalcifications. Inadequately treated DCIS carries a risk for evolving into the malignant phenotype; however, the magnitude and timeline for this risk are poorly defined. Treatment options include lumpectomy with or wi...... hiện toàn bộ